TLR7 and systemic lupus erythematosus: TLR7 evades X chromosome inactivation, leading to biallelic expression in immune cells such as B lymphocytes, which enhances immune responses and contributes to the increased susceptibility to systemic lupus erythematosus (SLE), as well as potentially impacting the efficacy of immune therapies targeting TLR7 (82).